Back to dashboard
Episode 108
DIP Episode 108 - ABIM/Medicine ITE/USMLE Step 3 Review Series 7 (Rheumatology 1)
ImmunologyMedium4 - HighHas Q&A
Step 1Step 2Step 3COMLEXMedicineUSMLEStep 1Step 2Step 3
Topic
Rheumatoid Arthritis (RA) vs. Osteoarthritis (OA); Inflammatory vs. Non-inflammatory arthritis...
Key Takeaway
The differential diagnosis between inflammatory (e.g., RA) and non-inflammatory (e.g., OA) arthritides is critical, requiring assessment of joint symmetry, morning stiffness duration, specific joint involvement patterns (DIPs vs. MCPs), and characteristic lab/imaging findings.
Runtime: 36.3 min
Published: 2019-05-31
Completed audio: Yes
Completed notes: Yes
Anki made: Yes
Section: —
Episode Notes
Source / episode info
- Episode: 108
- Title: Divine Intervention Episode 108 – ABIM/Medicine ITE/USMLE Step 3 Review Series 7 (Rheumatology 1)
- Published: 2019-05-31
- Source: Episode page
One-liner
This episode provides a comprehensive comparison of Osteoarthritis and Rheumatoid Arthritis, detailing classic physical exam signs (e.g., RA's swan neck deformity vs. OA's Heberden's nodes), diagnostic criteria (joint fluid analysis, specific antibodies like anti-CCP), high-yield complications (Felty syndrome, vasculitis), and the complex pharmacology of DMAR Ds, including pregnancy safety and toxicity management.
High-yield summary
- OA vs RA Joint Pattern: OA is typically asymmetric, affects DI Ps/first CMC joint primarily, and causes bony overgrowth (osteophytes). RA is symmetric, affects MC Ps/wrists prominently, and spares the DI Ps.
- Inflammatory Markers: Inflammatory arthritis shows elevated ESR/CRP, warm/red joints, prolonged morning stiffness (>1 hour), and highly inflammatory synovial fluid (WBC >2000, Neutrophil % >75%).
- RA Diagnostic Criteria: Key antibodies include Rheumatoid Factor (RF) (IgM anti-IgG) and the more specific Anti-CCP antibody. Imaging classically shows periarticular osteopenia and marginal erosions.
- DMARD Management Pearls: Methotrexate is a folate antagonist; its toxicity requires monitoring of LF Ts, PF Ts (reduced DLCO), and managing bone marrow suppression by administering Leucovorin (Folinic acid) rescue.
- Pregnancy Safety: The two DMAR Ds considered safe in pregnancy are Hydroxychloroquine and Sulfasalazine. Methotrexate and Leflunomide are teratogenic.
- RA Complications & Screening: High suspicion for Felty syndrome (RA + Neutropenia + Splenomegaly) is warranted, and all patients starting TNF inhibitors require screening for latent Tuberculosis (TB).
Learning objectives
- Differentiate the clinical presentation, joint distribution, and radiographic findings of Osteoarthritis versus Rheumatoid Arthritis.
- Identify key diagnostic markers for RA (RF, anti-CCP) and associated complications (Felty syndrome).
- Understand the mechanism of action and toxicity profile of Methotrexate and other DMAR Ds, including folate antagonism and rescue therapy.
- Apply knowledge of drug safety in pregnancy when selecting appropriate rheumatologic agents.
- Recognize high-risk patient populations for atlantoaxial instability due to chronic inflammatory arthritides.
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Osteoarthritis (OA) | Asymmetric joint pain; Medial knee involvement | Osteophytes, subchondral sclerosis/cysts | Remember the classic nodes: Heberden's (DI Ps) and Bouchard's (PI Ps). |
| Rheumatoid Arthritis (RA) | Symmetric polyarthritis; Morning stiffness > 1 hour | Anti-CCP antibody, marginal erosions, periarticular osteopenia | The DIP joints are classically spared in RA. |
| Methotrexate (MTX) | Folate antagonism; Bone marrow suppression | LFT elevation, pneumonitis/fibrosis | Always administer Leucovorin rescue when MTX is combined with other folate antagonists (e.g., TMP-SMX). |
| Hydroxychloroquine | Safe in pregnancy DMARD | Lupus and RA treatment | It is one of the two safest agents for pregnant patients needing rheumatologic care. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| OA Joint Examination | Pain worse with weight-bearing; Stiffness < 1 hour | Medial joint line pain (knee); Osteophytes visible on exam/imaging. | Helps distinguish OA from inflammatory arthritis, which worsens with movement. |
| RA Deformities | Swan neck: PIP extended, DIP flexed; Boutonniere: PIP flexed, DIP extended | Remembering the S-E-F mnemonic (Swan Neck) is key for recall. | These specific deformities are classic signs of chronic RA inflammation. |
| DMARD Toxicity | MTX + TMP-SMX = Folate antagonism | Profound bone marrow suppression; requires Leucovorin rescue. | This combination represents a critical drug interaction/toxicity scenario on exams. |
| RA C-spine Risk | Ankylosing Spondylitis, GIA, RA (long standing), Down Syndrome | Need for C-spine X-ray with flexion and extension views pre-operatively. | A high-yield list of four populations to remember for spinal instability risk. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| A 65-year-old obese man presents with asymmetric knee pain, limited to the medial joint line, and X-rays show osteophytes. | Osteoarthritis (OA) | OA is typically asymmetric, involves weight-bearing joints, and causes bony remodeling/osteophyte formation. |
| A patient with RA undergoes surgery; pre-operative imaging must include C-spine flexion/extension views due to risk of atlantoaxial instability. | Rheumatoid Arthritis (RA) / Atlantoaxial Instability | Chronic inflammation in RA can destroy ligaments/cartilage at the C1-C2 joint, risking spinal cord injury during manipulation. |
| A patient with RA presents with pancytopenia and massive splenomegaly. | Felty Syndrome | This triad (RA + Neutropenia + Splenomegaly) is a classic, high-yield complication of severe RA. |
| A rheumatologist initiates treatment for RA using Methotrexate but notes the patient develops nonproductive cough, fever, and reduced DLCO on PF Ts. | MTX Pneumonitis/Fibrosis | These symptoms suggest drug toxicity; monitoring PF Ts (especially DLCO) is crucial for methotrexate-induced pulmonary fibrosis. |
| A pregnant woman with RA requires DMARD therapy. Which agent should be prioritized? | Hydroxychloroquine or Sulfasalazine | Both are recognized as the safest DMARD options during pregnancy, avoiding teratogenic agents like MTX and Leflunomide. |
| The patient's joint fluid analysis reveals a WBC count of 15,000 cells/mm^3 with >80% neutrophils. | Inflammatory Arthritis (e.g., Septic or RA) | High WBC counts and high neutrophil predominance strongly indicate an active inflammatory process, differentiating it from OA. |
Differential diagnosis / distinguishing features
Inflammatory Arthritis vs Septic Arthritis
| Key Features | Distinguishing Findings | Next Step |
| Inflammatory: Warm/red joints; Elevated ESR/CRP; Synovial fluid WBC >2000, Neutrophil % >75%. | Septic: Usually acute onset; High fever; Joint destruction. | Aspiration and culture of joint fluid is mandatory for diagnosis. |
Management pearls
- For RA patients undergoing elective surgery: Always obtain C-spine X-rays with flexion/extension views if the patient has a history of RA, Ankylosing Spondylitis, GIA, or Down syndrome.
- When initiating MTX therapy in RA, monitor LF Ts and PF Ts (especially DLCO) for signs of pneumonitis or fibrosis.
- If bone marrow suppression occurs due to combined folate antagonists (e.g., MTX + TMP-SMX), administer Leucovorin rescue immediately.
- In pregnancy, prioritize Hydroxychloroquine or Sulfasalazine over Methotrexate or Leflunomide for RA management.
Don't miss
🚨
The classic triad of Felty syndrome is Rheumatoid Arthritis, Neutropenia, and Splenomegaly.
🚨
Anti-CCP antibodies are more specific than RF antibodies for diagnosing RA.
🚨
MTX pneumonitis can mimic other pulmonary diseases; monitor PF Ts (FEV1/FVC ratio > 0.8, reduced DLCO).
🚨
The two DMAR Ds safe in pregnancy are Hydroxychloroquine and Sulfasalazine.
Integration & clinical reasoning
- Rheumatology & Hematology: RA is associated with chronic inflammation leading to Anemia of Chronic Disease (ACD), which typically presents with high ferritin levels.
- Rheumatology & Neurology: Long-standing RA increases the risk of vasculitis, pleuritis, and can cause CNS complications like aseptic meningitis or pneumonias (e.g., Caplan syndrome).
- Pharmacology Integration: Understanding folate antagonism is key; MTX, TMP-SMX, and Pyrimethamine all inhibit dihydrofolate reductase, necessitating Leucovorin rescue.
OMM / COMLEX integration
🦴
For COMLEX: know these viscerosomatics / Chapman points, but don't let OMM distract from emergent diagnosis and management.
- Acute/Unstable Management: In any acute inflammatory flare, standard emergency management (NSAI Ds, corticosteroids) takes priority over DMAR Ds. MTX is generally not used acutely due to potential for pulmonary toxicity.
- Rheumatology & GI: RA can cause vasculitis and gut inflammation; monitoring bowel function and considering anti-inflammatory agents is key.
Concept connections / cross-references
- No explicit cross-references.
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Osteoarthritis | Osteophytes, Subchondral sclerosis | Cartilage wear leading to reactive bone formation. | Helps differentiate OA from inflammatory arthritis; osteophyte formation is a hallmark of mechanical joint stress. |
| Rheumatoid Arthritis (RA) | Anti-CCP antibodies | Autoantibody targeting citrullinated peptides. | Highly specific marker for RA, often detected before clinical symptoms appear. |
| Methotrexate | Folate antagonism | Inhibits dihydrofolate reductase, disrupting DNA synthesis. | Requires careful monitoring and rescue with Leucovorin when combined with other folate antagonists. |
| Hydroxychloroquine | Lupus/RA treatment; Pregnancy safety | Immunomodulatory effects (mechanism complex). | It is one of the two DMAR Ds recommended for use in pregnancy due to its low teratogenicity risk. |
Key terms glossary
| Term | Definition | Context | Example |
| Periarticular Osteopenia | Radiographic thinning/loss of bone density around a joint capsule. | RA imaging finding; indicates chronic inflammation and local bone resorption. | Seen classically at the wrist or metacarpophalangeal joints in RA. |
| Anti-CCP Antibody | Anti-cyclic citrullinated peptide antibody. | Specific serological marker for Rheumatoid Arthritis (RA). | Positive anti-CCP significantly increases the pre-test probability of RA diagnosis. |
| Leucovorin Rescue | Administration of folinic acid (a reduced folate analog). | Treatment for bone marrow suppression caused by MTX or other folate antagonists. | Used when a patient on Methotrexate is given Trimethoprim-Sulfamethoxazole to prevent profound myelosuppression. |
| Atlantoaxial Instability | Malalignment between the C1 (atlas) and C2 (axis) vertebrae. | Risk factor in RA, Ankylosing Spondylitis, GIA, Down Syndrome. | Requires mandatory pre-operative C-spine X-rays with flexion/extension views. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| OA vs RA Comparison | Create a comparison table (symptoms, joints, imaging). | High | Clinical vignettes and physical exam practice. |
| DMARD Pharmacology | Focus on mechanism of action, toxicity, and contraindications. | Critical | Memorize the safe agents in pregnancy (HCQ, Sulfasalazine) and the rescue agent (Leucovorin). |
| RA Complications | Use mnemonics/triads for high-yield associations. | High | Felty Syndrome (R+N+S), C-spine instability groups (A+GIA+RA+D). |
Question pattern recognition
- The "Safe in Pregnancy" Pattern: When a pregnant patient needs DMARD therapy, the answer is almost always Hydroxychloroquine or Sulfasalazine.
- The "Folate Antagonism" Trap: Recognizing that MTX and TMP-SMX both inhibit folate pathways, necessitating Leucovorin rescue.
- The "Joint Pattern" Distinction: Using joint symmetry (RA) vs. asymmetry (OA), and specific joints affected (DI Ps spared in RA).
Test yourself
Common mistakes to avoid
🚫
Mistake 1: Confusing OA/RA Joint Involvement: Assuming that because the patient has polyarthritis, it must be RA. Always check for DIP sparing (suggests RA) and joint symmetry/pattern (OA vs RA).
🚫
Mistake 2: Misinterpreting Synovial Fluid: Thinking a high WBC count always means septic arthritis. While highly inflammatory, chronic RA can also show elevated counts; the pattern helps differentiate.
🚫
Mistake 3: Forgetting Leucovorin Rescue: Failing to recognize that MTX is a folate antagonist and must be rescued when combined with other agents like TMP-SMX.
Common traps
⚠️
Trap 1 (The "Osteophyte" Trap): Assuming all osteophytes are benign. They can cause soft tissue impingement and deformity, but the presence of osteophytes itself points strongly toward OA/mechanical stress.
⚠️
Trap 2 (The "Primary AI" Trap - Not applicable here ): Be careful not to confuse RA's inflammatory markers with primary adrenal insufficiency physiology (e.g., hyperkalemia).
⚠️
Trap 3 (The "DMARD Safety" Trap): Selecting Methotrexate or Leflunomide in a pregnant patient when safer alternatives like Hydroxychloroquine are available.